Frequency-dependent drug screening using optogenetic stimulation of human iPSC-derived cardiomyocytes.

about

Frequency-Dependent Multi-Well Cardiotoxicity Screening Enabled by Optogenetic Stimulation.Modeling Hematological Diseases and Cancer With Patient-Specific Induced Pluripotent Stem Cells

P2860

Q47278228-F3BA7891-B1E3-407A-8E02-3BEB6B4E0895 Q57490090-52231B80-90AE-4D08-81BF-1729E3E3B39D

P2860

Frequency-dependent drug screening using optogenetic stimulation of human iPSC-derived cardiomyocytes.

Item

http://www.wikidata.org/entity/Q40065981

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Frequency-dependent drug scree ...... n iPSC-derived cardiomyocytes.

@en

type

Item

label

Frequency-dependent drug scree ...... n iPSC-derived cardiomyocytes.

@en

prefLabel

Frequency-dependent drug scree ...... n iPSC-derived cardiomyocytes.

@en

P1476

Frequency-dependent drug scree ...... an iPSC-derived cardiomyocytes

@en

P2093

Alexandra Heidsieck

http://www.w3.org/2001/XMLSchema#string

Carsten Kilgus

http://www.w3.org/2001/XMLSchema#string

Daniela Malan

http://www.w3.org/2001/XMLSchema#string

Hendrik Lapp

http://www.w3.org/2001/XMLSchema#string

Stephanie Friedrichs

http://www.w3.org/2001/XMLSchema#string

P2860

A KCNQ1 mutation contributes to the concealed type 1 long QT phenotype by limiting the Kv7.1 channel conformational changes associated with protein kinase A phosphorylation

A molecular mechanism for adrenergic-induced long QT syndrome

Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion

Induced pluripotent stem cell-derived cardiomyocytes in studies of inherited arrhythmias

Induced pluripotent stem cells as a disease modeling and drug screening platform

OptoDyCE as an automated system for high-throughput all-optical dynamic cardiac electrophysiology.

Human iPS cell model of type 3 long QT syndrome recapitulates drug-based phenotype correction

Simulation of the undiseased human cardiac ventricular action potential: model formulation and experimental validation

Small and large animal models in cardiac contraction research: advantages and disadvantages

Light activation of channelrhodopsin-2 in excitable cells of Caenorhabditis elegans triggers rapid behavioral responses

P2888

s41598-017-09760-7

P304

9629

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-09760-7

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tobias Bruegmann

Philipp Sasse

P577

2017-08-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28851973

http://www.w3.org/2001/XMLSchema#string

P921

drug screening

P932

5575076

http://www.w3.org/2001/XMLSchema#string

Frequency-dependent drug screening using optogenetic stimulation of human iPSC-derived cardiomyocytes.

about

P2860

P2860

Frequency-dependent drug screening using optogenetic stimulation of human iPSC-derived cardiomyocytes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932